FDA Inspection
Medistat RX L.L.C.Medistat RX L.L.C. – FDA Inspection, Sep 18, 2014
Record Details
This FDA Inspection record concerns Medistat RX L.L.C., with an inspection on September 18, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Medistat RX L.L.C.
- Inspection Date
- September 18, 2014
- Product Type
- Drugs
View Company Profile
ID · b1c81ff2-a6d1-4396-bec8-de235834f52e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 899230
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
10- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.167(a)Sterility/pyrogen-free testing
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.198(a)Complaints reviewed by Quality Control Unit
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medistat RX L.L.C.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medistat RX L.L.C.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.